Comparative analysis of endovascular interventional therapy and simple drug therapy in patients with ischemic cerebrovascular disease
10.3969/j.issn.1005-1678.2017.09.158
- VernacularTitle:缺血性脑血管病患者行血管内介入及单纯药物治疗的效果对比
- Author:
Yongbin WU
;
Ying JI
;
Na TANG
- Keywords:
ischemic cerebrovascular disease;
endovascular interventional therapy;
simple drug therapy;
clinical effect
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(9):354-356
- CountryChina
- Language:Chinese
-
Abstract:
Objective this research mainly analysis in the treatment of patients with ischemic cerebrovascular disease by comparison of clinical therapeutic effect of endovascular treatment and simple drug treatment. Methods 60 cases of patients with ischemic cerebrovascular disease admitted in our hospital from January 2016 to January 2017, and were randomly divided into control group and observation group, 30 cases in each group. The control group were treated by endovascular treatment, the observation group were treated with simple drug treatment, the two groups of patients treated for 6 months, 12 months to improve blood flow, the incidence of cerebrovascular events, mortality, prognosis Quality of life scores as a comparison basis.Results The patients in the observation group were treated for 6 months, 12 months after the blood flow improved superior to the patients in the control group (P<0.05); the patients in the observation group were treated for 6 months, 12 months of cerebrovascular disease incidence rate lower than that of the control group (P<0.05); the observation group after 6 months treatment and mortality of patients in the control group had no significant difference; the patients in the observation group after 12 months of treatment the mortality rate lower than that of the control group (P<0.05). The patients in the observation group survival quality scores were excellent in the control group (P<0.05). Conclusion The study proves that, in the treatment of patients with ischemic cerebrovascular disease in the treatment can effectively improve the treatment effect of endovascular intervention, improve the blood flow status of patients, reduce the events in patients with cerebrovascular disease incidence and mortality.
